| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | EP1088062B1 Transplants for myocardial scars |
| 03/04/2009 | EP1078006B1 Diagnosis and treatment of hepatic disorders |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | EP1037918B1 Compositions to enhance the efficacy of a vaccine using chemokines |
| 03/04/2009 | EP1021542B1 Apo-3 ligand |
| 03/04/2009 | EP0988054B1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 03/04/2009 | EP0869974B1 Compounds with growth hormone releasing properties |
| 03/04/2009 | CN101379189A Modified coagulation factor VIIa with extended half-life |
| 03/04/2009 | CN101379182A Skin care compositions and treatments |
| 03/04/2009 | CN101379088A Bispecific ligands with binding specificity to cell surface targets and methods of use therefor |
| 03/04/2009 | CN101379087A Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling |
| 03/04/2009 | CN101379084A Novel anticoagulant polypeptides and complex |
| 03/04/2009 | CN101379083A Apoptosis-induced protein compound and therapy application thereof |
| 03/04/2009 | CN101378783A Methods and compositions for expanding T regulatory cells |
| 03/04/2009 | CN101378775A Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 03/04/2009 | CN101378774A Method for therapies of pulmonary diseases using interferon |
| 03/04/2009 | CN101378773A Stable protein formulations |
| 03/04/2009 | CN101378772A Tissue protective peptides and uses thereof |
| 03/04/2009 | CN101377487A Application of human transcription co-activate factor PC4 in preparations for preparing, diagnosing, curing or preventing tumor |
| 03/04/2009 | CN101376875A Pichia yeast expressing recombinant human blood coagulation factor VII, and preparation and use thereof |
| 03/04/2009 | CN101376676A PEGylated erythropoietin protein long-acting preparation |
| 03/04/2009 | CN101376675A Antimicrobial peptide |
| 03/04/2009 | CN101376022A Medicament composition containing defibrase modified by PEG |
| 03/04/2009 | CN101376021A Application of recombinant human interferon gamma in preparing medicament for treating tumor |
| 03/04/2009 | CN101376020A Application of fungal immunomodulatory protein for inhibiting delta 5-desaturated enzyme |
| 03/04/2009 | CN100465270C Nereides protease, and a separating and purifying method and an application thereof |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464781C Nutrition liquid for chronic nephropathy and a preparation method thereof |
| 03/04/2009 | CN100464735C A preparation method of hydro-acupuncture of liver cell growth promoting factors |
| 03/04/2009 | CN100464639C A composition with heart rate reducing property |
| 03/03/2009 | US7498424 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498412 Process for preparing porous collagen matrix from connective tissue |
| 03/03/2009 | US7498408 Ryanodine receptor polypeptides |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498404 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections |
| 03/03/2009 | US7498403 Peptides capable of binding to titanium silver silicone |
| 03/03/2009 | US7498332 Therapy for cerebral vasospasm |
| 03/03/2009 | US7498313 Large circular target-specific antisense nucleic acid compounds |
| 03/03/2009 | US7498310 Applying a water in oil emulsion of a tetrapeptide: H2N-Valine-Valine-Arginine-Proline or one of its amide derivatives |
| 03/03/2009 | US7498309 Containing a suspending agent (oleoyl macrogol glyceride), and a dispersant (silica sol); treating intestinal bowel disease, Crohn's disease, or colitis, or inflammatory conditions resulting from cytoablative treatment or HIV infection. |
| 03/03/2009 | US7498308 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo |
| 03/03/2009 | US7498307 Treating a gram negative bacterial infection with a synergistic mixture of a DnaK inhibitor such as pyrrhocoricin or drosocin and another bactericide such as fluoroquinolone, beta-lactam, tetracycline, macrolide, aminoglycoside, glycopeptide, or folic acid synthesis inhibitor family of antibiotics. |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498305 Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity |
| 03/03/2009 | US7498304 Angiogenesis-modulating compositions and uses |
| 03/03/2009 | US7498303 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498300 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders |
| 03/03/2009 | US7498299 Optionally containing a recognition sequence for affinity purification; treating fibrotic liver disorders |
| 03/03/2009 | US7498298 Monomethylvaline compounds capable of conjugation to ligands |
| 03/03/2009 | US7498297 Medicinal uses of mu-opioid receptor agonists |
| 03/03/2009 | US7498165 Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins |
| 03/03/2009 | US7498162 A gene expressed polypeptide is used in food, for treating food allergy |
| 03/03/2009 | US7498158 Termamyl-like alpha-amylase for starch conversion, ethanol, laundry, dish, hard surface cleaning, textile desizing and/or sweetner production |
| 03/03/2009 | US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/03/2009 | US7498152 Interferon-alpha polypeptides and conjugates |
| 03/03/2009 | US7498149 Proteins having effects of controlling cell migration and cell death |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498146 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498138 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 03/03/2009 | US7498134 HAUSP-Mdm2 interaction and uses thereof |
| 03/03/2009 | US7498128 Methods of determining contributions to metabolic pathways |
| 03/03/2009 | US7498046 Composition for inducing immune response comprising inverted microsomes |
| 03/03/2009 | US7498045 Biodegradable polymeric nanocapsules and uses thereof |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498027 Methods of treatment using human tumor necrosis factor receptor TR17 antibodies |
| 03/03/2009 | US7498026 Nucleotide sequence encoding an acyltransferase polypeptide comprising membrane-spanning region; immobilization, freeze drying; contacting vegetable oil with polypeptide wherein fatty acids are transferred from phospholipid to an acceptor molecule; ester interchange; lecithin is converted to lysolecithin |
| 03/03/2009 | US7498025 Targeted bifunctional molecules and therapies based thereon |
| 03/03/2009 | US7498021 Peptide that binds to integrins |
| 03/03/2009 | US7497855 Method and device for the controlled delivery of parathyroid hormone |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2356197C Thin polymer film drug reservoirs |
| 03/03/2009 | CA2276108C Novel peptide, novel dna, and novel antibody |
| 03/03/2009 | CA2270286C Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 03/03/2009 | CA2238278C Antigenic protein originating in malassezia |
| 02/26/2009 | WO2009026539A1 Treatment with kallikrein inhibitors |
| 02/26/2009 | WO2009026529A1 Compositions and methods using variant tat proteins |
| 02/26/2009 | WO2009026412A1 Treatment of airway hyperreactivity |
| 02/26/2009 | WO2009026393A2 Amino acid substituted molecules |
| 02/26/2009 | WO2009026334A2 Treatment with kallikrein inhibitors |
| 02/26/2009 | WO2009026282A2 Compositions for the treatment of stroke or cerebrovascular accidents with an endothelin b receptor agonist |
| 02/26/2009 | WO2009026233A2 Self assembling peptide systems and methods |
| 02/26/2009 | WO2009026112A2 Antimicrobial peptides |
| 02/26/2009 | WO2009026106A1 Methods for promoting stem cell proliferation and survival |
| 02/26/2009 | WO2009026083A1 ζA MEMORY INFLUENCING PROTEIN |
| 02/26/2009 | WO2009025958A1 Erythropoietin rceptor peptide formulations and uses |
| 02/26/2009 | WO2009025957A1 Erythropoietin receptor peptide formulations and uses |
| 02/26/2009 | WO2009025864A1 Methods of treating and protecting against human immunodeficiency virus |
| 02/26/2009 | WO2009025830A1 Treatment of lung cancer |
| 02/26/2009 | WO2009025797A1 Compositions and methods for treating symptoms of aging |
| 02/26/2009 | WO2009025763A2 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues |
| 02/26/2009 | WO2009025760A2 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |